Development of improved cholera vaccine based on subunit toxoid.

Synergistic protection against experimental cholera by immunization with cholera toxoid and vaccine.

An oral B subunit: whole cell vaccine against cholera.

Preparation of a purified antigenic cholera toxoid.

Development of improved pertussis vaccine.

Recent advancements in combination subunit vaccine development.

Antigenicity of purified glutaraldehyde-treated cholera toxoid administered orally.

Mucosal Vaccine Development Based on Liposome Technology.

Oral cholera vaccine development and use in Vietnam.

The oral cholera vaccine: meeting Millennium Development Goal Six.

Comparative whole-genome analyses of selection marker-free rice-based cholera toxin B-subunit vaccine lines and wild-type lines.

Overprescription of cholera vaccine.

Overprescription of cholera vaccine.

Stimulation of the transepithelial flux of influenza HA vaccine by cholera toxin B subunit.

whole-cell cholera vaccine.

Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers.

Recombinant toxin-coregulated pilus A (TcpA) as a candidate subunit cholera vaccine.

N-glycosylation of cholera toxin B subunit in Nicotiana benthamiana: impacts on host stress response, production yield and vaccine potential.

Development of improved vaccine cell lines against rotavirus.

The first British reference preparations of cholera vaccine (Inaba) and of cholera vaccine (Ogawa).

A novel protein-based subunit Shigella vaccine candidate.

Embracing oral cholera vaccine--shifting response to cholera.

Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine.

Effectiveness of oral cholera vaccine in Haiti.

Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine.

Suggest Documents

Synergistic protection against experimental cholera by immunization with cholera toxoid and vaccine.

An oral B subunit: whole cell vaccine against cholera.

Preparation of a purified antigenic cholera toxoid.

Development of improved pertussis vaccine.

Recent advancements in combination subunit vaccine development.

Antigenicity of purified glutaraldehyde-treated cholera toxoid administered orally.

Mucosal Vaccine Development Based on Liposome Technology.

Oral cholera vaccine development and use in Vietnam.

The oral cholera vaccine: meeting Millennium Development Goal Six.

Comparative whole-genome analyses of selection marker-free rice-based cholera toxin B-subunit vaccine lines and wild-type lines.

Overprescription of cholera vaccine.

Overprescription of cholera vaccine.

Stimulation of the transepithelial flux of influenza HA vaccine by cholera toxin B subunit.

whole-cell cholera vaccine.

Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers.

Recombinant toxin-coregulated pilus A (TcpA) as a candidate subunit cholera vaccine.

N-glycosylation of cholera toxin B subunit in Nicotiana benthamiana: impacts on host stress response, production yield and vaccine potential.

Development of improved vaccine cell lines against rotavirus.

The first British reference preparations of cholera vaccine (Inaba) and of cholera vaccine (Ogawa).

A novel protein-based subunit Shigella vaccine candidate.

Embracing oral cholera vaccine--shifting response to cholera.

Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine.

Effectiveness of oral cholera vaccine in Haiti.

Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine.

Development of improved cholera vaccine based on subunit toxoid.

Recommend Documents

Follow Us